Tocilizumab and Aflibercept as a Treatment Option for Refractory Macular Edema after Acute Retinal Necrosis

Bograd, Alexandra; Villiger, Peter M.; Munk, Marion R.; Bolt, Isabel; Tappeiner, Christoph (2023). Tocilizumab and Aflibercept as a Treatment Option for Refractory Macular Edema after Acute Retinal Necrosis. Ocular immunology and inflammation, 31(1), pp. 242-245. Taylor & Francis 10.1080/09273948.2021.2024580

[img] Text
tocilizumab_und_aflibercept_arn.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (2MB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine > Paediatric Rheumatology

UniBE Contributor:

Bograd, Alexandra Emma Olga, Munk, Marion, Bolt, Isabel Bettina, Tappeiner, Christoph

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1744-5078

Publisher:

Taylor & Francis

Language:

English

Submitter:

Anette van Dorland

Date Deposited:

08 Feb 2022 14:41

Last Modified:

26 Jan 2023 00:11

Publisher DOI:

10.1080/09273948.2021.2024580

PubMed ID:

35060816

BORIS DOI:

10.48350/164727

URI:

https://boris.unibe.ch/id/eprint/164727

Actions (login required)

Edit item Edit item
Provide Feedback